Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/167442
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLópez Arnau, Raúl-
dc.contributor.authorBuenrostro Jáuregui, Mario-
dc.contributor.authorCamarasa García, Jordi-
dc.contributor.authorPubill Sánchez, David-
dc.contributor.authorEscubedo Rafa, Elena-
dc.date.accessioned2020-07-03T09:07:55Z-
dc.date.available2020-07-03T09:07:55Z-
dc.date.issued2018-01-18-
dc.identifier.issn0028-1298-
dc.identifier.urihttp://hdl.handle.net/2445/167442-
dc.description.abstractCathinones, such as mephedrone (Meph), are often co-abused with alcoholic drinks. In the present study, we investigated the combined effects of Meph plus ethanol (EtOH) on neurotransmitter release in the nucleus accumbens (NAc) and the medial prefrontal cortex (mPFC). A guide canula was stereotaxically implanted into either the NAc or the mPFC of male Sprague-Dawley rats. Seven days after surgery, a microdialysis probe was inserted and rats were administered saline, EtOH (1 g/kg, i.p.), Meph (25 mg/kg, s.c.), or their combination, and dialysates were collected. Serotonin (5-HT), dopamine (DA), and their metabolites (5-HIAA, DOPAC and HVA) were determined through high-pressure liquid chromatography coupled to mass spectrometry. 5-HT and DA peaked 40 min after Meph administration (with or without EtOH co-treatment) in both areas. EtOH combined with Meph increased the 5-HT release compared with the rats receiving Meph alone (85% in NAc, 65% in mPFC), although the overall change in the area under the curve only reached statistical significance in the NAc. In mPFC, the increased release of 5-HT lasted longer in the combination than that in the Meph group. Moreover, EtOH potentiated the psychostimulant effect of Meph measured as a locomotor activity. Given that both 5-HT and DA are also related with reward and impulsivity, the observed effects point to an increased risk of abuse liability when combining Meph with EtOH compared with consuming these drugs alone.-
dc.format.extent8 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherSpringer Verlag-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1007/s00210-018-1464-x-
dc.relation.ispartofNaunyn-Schmiedebergs Archives of Pharmacology, 2018, vol. 391, num. 3, p. 247-254-
dc.relation.urihttps://doi.org/10.1007/s00210-018-1464-x-
dc.rights(c) Springer Verlag, 2018-
dc.sourceArticles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)-
dc.subject.classificationFarmacologia-
dc.subject.classificationFarmacocinètica-
dc.subject.classificationAmfetamines-
dc.subject.classificationDrogoaddicció-
dc.subject.classificationRates (Animals de laboratori)-
dc.subject.otherPharmacology-
dc.subject.otherPharmacokinetics-
dc.subject.otherAmphetamines-
dc.subject.otherDrug addiction-
dc.subject.otherRats as laboratory animals-
dc.titleEffect of the combination of mephedrone plus ethanol on serotonin and dopamine release in the nucleus accumbens and medial prefrontal cortex of awake rats-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.identifier.idgrec675606-
dc.date.updated2020-07-03T09:07:55Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
Articles publicats en revistes (Institut de Biomedicina (IBUB))

Files in This Item:
File Description SizeFormat 
675606.pdf550.73 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.